How do I calculate the FIB-4 score for a patient with hepatic steatosis, obesity, diabetes, and hypercholesterolemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Calculate the FIB-4 Score

The FIB-4 score is calculated using a simple formula: Age (years) × AST (IU/L) / [Platelet count (×10⁹/L) × √ALT (IU/L)]. 1

Required Laboratory Values

You need exactly four values to calculate FIB-4: 1

  • Age in years
  • AST (aspartate aminotransferase) in IU/L
  • ALT (alanine aminotransferase) in IU/L
  • Platelet count in ×10⁹/L (or cells/mm³ divided by 1,000)

Practical Calculation Steps

Step 1: Multiply the patient's age by their AST level 2

Step 2: Take the square root of the ALT value 2

Step 3: Multiply the platelet count by the square root of ALT 2

Step 4: Divide the result from Step 1 by the result from Step 3 2

Many free online calculators are available (such as https://www.mdcalc.com/fibrosis-4-fib-4-index-liver-fibrosis) that perform this calculation automatically. 2

Interpreting Your Results

For Patients Under 65 Years Old:

  • FIB-4 <1.3: Low probability of advanced fibrosis (negative predictive value ~90%) - repeat testing in 2-3 years 2
  • FIB-4 1.3-2.67: Indeterminate risk - requires additional testing with liver stiffness measurement (LSM) by transient elastography or Enhanced Liver Fibrosis (ELF) blood test 2
  • FIB-4 >2.67: High probability of advanced fibrosis - refer to hepatologist for comprehensive evaluation 2

For Patients 65 Years and Older:

Use a higher lower cutoff of 2.0 instead of 1.3 to rule out advanced fibrosis, as age significantly affects FIB-4 values and leads to higher false-positive rates in elderly patients. 2 The upper cutoff of 2.67 remains unchanged. 2

Special Considerations for Your Patient Population

Diabetes Impact on FIB-4 Accuracy:

FIB-4 performs less accurately in patients with diabetes, with a c-statistic of only 0.68 in diabetic patients compared to 0.85 in non-diabetic patients. 3 This means FIB-4 may miss some cases of advanced fibrosis in your patient with diabetes, obesity, and metabolic syndrome. 4

Obesity Considerations:

FIB-4 accuracy also varies by weight status, with reduced performance in normal weight individuals (c-statistic 0.65) compared to overweight patients (c-statistic 0.85). 3

What to Do After Calculating FIB-4

If FIB-4 is Low (<1.3 or <2.0 if age ≥65):

  • Advanced fibrosis is unlikely 2
  • Repeat FIB-4 testing every 2-3 years 2
  • Continue management with primary care, dietician, endocrinologist for metabolic risk factors 2

If FIB-4 is Indeterminate (1.3-2.67):

  • Proceed immediately to liver stiffness measurement (LSM) by vibration-controlled transient elastography (VCTE/FibroScan) 2
  • If LSM <8 kPa: Low risk, repeat testing in 2-3 years 2
  • If LSM 8-12 kPa: Indeterminate risk, refer to hepatologist for monitoring 2
  • If LSM >12 kPa: High risk, refer to hepatologist for further evaluation 2
  • If elastography unavailable, use Enhanced Liver Fibrosis (ELF) blood test as alternative (ELF <7.7 indicates low risk) 2

If FIB-4 is High (>2.67):

  • Immediate referral to hepatologist is mandatory 2
  • High probability of advanced fibrosis (positive predictive value 60-80%) 2, 1
  • Hepatologist will perform additional testing (elastography, possible liver biopsy, or MR elastography) 2

Critical Pitfalls to Avoid

Do not use a second non-proprietary diagnostic panel (such as NAFLD fibrosis score) if FIB-4 is indeterminate, as these generally do not perform better than FIB-4 and add no additional value. 2 Instead, proceed directly to elastography or ELF testing.

FIB-4 has limited positive predictive value - a high score does not definitively confirm advanced fibrosis, only indicates high probability requiring further evaluation. 2, 1

Age is a major confounder - FIB-4 naturally increases with age independent of fibrosis, leading to false positives in elderly patients and potential false negatives in younger patients (<35 years). 2, 1

In patients with diabetes and metabolic syndrome, FIB-4 may underperform, so maintain a lower threshold for proceeding to elastography even with borderline scores. 4, 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.